News

Cooperation for the development of immunotherapies against ALL, obesity, diabetes mellitus type 2 and ASCVD.

Amine Tahiri has joined the Development Services Sales team with effect from 1 July 2015.

Rudi Vollmer becomes new Technical Managing Director of Greiner Bio-One GmbH, responsible for production and technology.

Acquisition adds novel angiotensin II Type 2 receptor antagonist for the treatment of neuropathic pain to Novartis' industry-leading development pipeline.

Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.

Scientists reveal new methods for producing biochemicals based on existing pathways found in other organisms.

The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.

Researchers at the University of Illinois have identified a molecular mechanism that directs embryonic stem cells to mature into endothelial cells.

New “Biotype Innovation” to develop workflows for personalized health-care and other applications based on QIAGEN’s ModaPlex platform.

Sex differences in the CNS; new clues about trauma memory; measuring bird brains, and more.